Three major clinical advances address cardiometabolic disease management: prediabetes care shifts toward early intervention and prevention, crinecerfont enables sustained glucocorticoid reductions in congenital adrenal hyperplasia
Early Intervention And Cardiometabolic Prevention Prediabetes care focus
Sustained Glucocorticoid Reductions Over 2 Years Crinecerfont efficacy
Triple Combination Improves FEV1 And Lowers Severe Exacerbat Asthma therapy advancement
Triple Therapy Positive Results FEV1 improvement
2-Year Sustained Reduction crinecerfont efficacy
Severe Cases Lowered exacerbation reduction